Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NYSE:HIMS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.06-1.9%$2.83$2.12▼$4.87$1.57B1.967.02 million shs4.35 million shsHIMSHims & Hers Health$56.71-4.1%$51.45$16.05▼$72.98$12.82B2.1432.83 million shs20.70 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-2.50%+4.00%+19.08%+13.45%+10.64%HIMSHims & Hers Health+1.23%+2.24%+39.43%+23.38%+232.36%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.06-1.9%$2.83$2.12▼$4.87$1.57B1.967.02 million shs4.35 million shsHIMSHims & Hers Health$56.71-4.1%$51.45$16.05▼$72.98$12.82B2.1432.83 million shs20.70 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-2.50%+4.00%+19.08%+13.45%+10.64%HIMSHims & Hers Health+1.23%+2.24%+39.43%+23.38%+232.36%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.67Moderate Buy$4.3742.70% UpsideHIMSHims & Hers Health 1.92Reduce$38.92-31.38% DownsideCurrent Analyst Ratings BreakdownLatest CLOV and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025HIMSHims & Hers HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$68.008/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$48.00 ➝ $37.008/7/2025CLOVClover Health InvestmentsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.50 ➝ $4.108/6/2025CLOVClover Health InvestmentsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$4.50 ➝ $3.008/5/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold7/17/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$45.00 ➝ $48.00(Data available from 9/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.37B1.14N/AN/A$0.68 per share4.50HIMSHims & Hers Health$1.48B8.68$0.34 per share165.83$2.16 per share26.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$43.01M-$0.08N/AN/AN/A-2.68%-12.20%-6.95%11/5/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8070.89109.063.949.63%26.26%13.06%11/3/2025 (Estimated)Latest CLOV and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.801.80HIMSHims & Hers Health1.724.984.46Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%HIMSHims & Hers Health63.52%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments24.07%HIMSHims & Hers Health17.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680512.51 million389.15 millionOptionableHIMSHims & Hers Health1,637226.02 million185.99 millionOptionableCLOV and HIMS HeadlinesRecent News About These CompaniesOccidental Asset Management LLC Invests in Hims & Hers Health: A Closer Look at Recent DevelopmentsSeptember 29 at 7:15 PM | sohu.comSAbacus FCF Advisors LLC Reduces Stake in Hims & Hers Health: What It Means for InvestorsSeptember 29 at 7:15 PM | sohu.comSHims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's WhySeptember 29 at 6:46 PM | zacks.comFDA takes aim at Hims & Hers weight loss drugs in new advertising blitzSeptember 29 at 4:48 AM | hayspost.comHDakota Wealth Management Takes Position in Hims & Hers Health, Inc. $HIMSSeptember 29 at 3:47 AM | marketbeat.com3 Healthcare Stocks Using AI to Drive Growth (HIMS)...September 27 at 11:13 AM | marketbeat.comA Healthcare Debate: Progyny vs. Hims & HersSeptember 26, 2025 | msn.comModerately bullish activity in Hims and Hers Health with shares up 5.59%September 26, 2025 | msn.comHims & Hers: Navigating GLP Controversy With Aplomb, But Risks Warrant Hold RatingSeptember 26, 2025 | seekingalpha.comHims & Hers Health (NYSE:HIMS) Shares Up 5.7% - Here's WhySeptember 26, 2025 | marketbeat.comHims & Hers: Growth Meets FDA Scrutiny And Tariff RisksSeptember 26, 2025 | seekingalpha.comHims & Hers Powers YieldMax's Latest Options-Based Income ETFSeptember 26, 2025 | benzinga.comHIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?September 26, 2025 | zacks.comHims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on ItSeptember 26, 2025 | zacks.comBullish flow in Hims and Hers Health with shares up 3.1%September 25, 2025 | msn.comMichael Chi Sells 2,100 Shares of Hims & Hers Health (NYSE:HIMS) StockSeptember 25, 2025 | marketbeat.comInsider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 23,584 Shares of StockSeptember 25, 2025 | insidertrades.comHims and Hers Weight Loss SuccessSeptember 25, 2025 | wspa.comWOluyemi Okupe Sells 23,584 Shares of Hims & Hers Health (NYSE:HIMS) StockSeptember 24, 2025 | marketbeat.comKuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law FirmSeptember 24, 2025 | prnewswire.comOccidental Asset Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMSSeptember 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 20252 Data Center REITs That Look Good in Any PortfolioBy Sam Quirke | September 8, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Oracle Has Spoken: AI Changes EverythingBy Thomas Hughes | September 10, 2025Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut FrenzyBy Gabriel Osorio-Mazilli | September 21, 2025CLOV and HIMS Company DescriptionsClover Health Investments NASDAQ:CLOV$3.06 -0.06 (-1.92%) Closing price 04:00 PM EasternExtended Trading$3.07 +0.01 (+0.26%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Hims & Hers Health NYSE:HIMS$56.71 -2.41 (-4.08%) Closing price 03:59 PM EasternExtended Trading$56.47 -0.24 (-0.42%) As of 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 154% Jump in Bullish Bets: Is Ford About to Hit the Gas? AppLovin Stock Momentum Builds With $800+ Analyst Price Target Apple Stock Positioned for Holiday Gains With iPhone 17 Boost 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? This ETF Weeds Out Small-Cap Underperformers Chewy Stock: Why Analysts Say Boring May Be the Best Buy Dividend ETF SCHD Draws Buyers as Fed Cuts Spark Rotation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
